(PRWEB) September 20, 2012
ProPep Surgical, LLC, a privately-held, Austin-based medical device company, announced today it will be featuring it’s ProPep Nerve Monitoring System at the upcoming European Robotic Urology Symposium (ERUS) in London, September 26 – 28.
The ProPep Nerve Monitoring System is the first, real-time nerve identification system specifically designed for use during da Vinci® prostatectomy surgery. Fast, accurate and easy to use, the System aids a surgeon in identifying otherwise invisible nerves during minimally invasive robotic prostatectomy surgery and in so do, helps surgeon’s avoid inadvertent injury to these critical nerves. “ProPep Surgical is excited to participate in ERUS 2012. This event attracts key international thought leaders in robotic-assisted, minimally invasive, urology surgery from around the world.” said Jann Rasmussen, Vice President Sales and Marketing, ProPep Surgical. “ERUS is THE place to showcase new, innovative technologies that enhance this exciting field of modern medicine. ProPep Surgical is proud to be featuring our ProPep Nerve Monitoring System at this prestigious conference.”
The ERUS is an international symposium focused on showcasing the latest technologies and techniques in robotic-assisted, minimally invasive, urology surgery. The European Association of Urology is expecting over 400 of the world’s top robotic surgeons to attend. The symposium is being held at the Park Plaza Westminster Bridge in London and will include presentations, round table discussions and demonstrations, via live surgeries, of cutting edge techniques and technologies in robotic-assisted urology surgery.
About ProPep Surgical, LLC Established in 2010, ProPep Surgical is a privately-held, Austin-based medical device company developing a system of products (ProPep Nerve Monitoring System) to aid robotic surgeons in identifying otherwise invisible nerves during minimally invasive robotic surgery using the da Vinci Surgical System. Real time identification of these nerves will allow the surgeons to make a more informed decision about which tissue to selectively preserve or remove during da Vinci prostatectomies, da Vinci hysterectomies and colorectal surgery and as a result, potentially reduce the common side effects typically attributed to inadvertent nerve damage during these robotic surgical procedures.